Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: A prospective follow-up study

Respiratory Medicine

Volumn 138, Issue , 2018, Pages S24-S30

  Hendriks, Celine ^a,b,c   Drent, Marjolein ^a,c,d   De Kleijn, Willemien ^a,e   Elfferich, Marjon ^a   Wijnen, Petal ^a,f   De Vries, Jolanda ^a,g,h  

^a Ild Care Foundation Research Team   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^h TILBURG UNIVERSITY   (Netherlands)

Author keywords

Anxiety; Cognition; Depressive symptoms; Fatigue; Quality of life (QoL); Sarcoidosis; Small fiber neuropathy (SFN); Social support

Indexed keywords

ADULT; ANXIETY; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE FAILURE QUESTIONNAIRE; CORONARY ANGIOGRAPHY; DEPRESSION; DYSPNEA; EVERYDAY COGNITIVE FAILURE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LUNG LAVAGE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL PATIENT; MIDDLE AGED; NETHERLANDS; OUTCOME ASSESSMENT; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SCREENING TEST; SMALL FIBER NEUROPATHY; SMALL FIBER NEUROPATHY SCREENINGS LIST; SOCIAL SUPPORT; STRUCTURAL EQUATION MODELING; TERTIARY CARE CENTER; UNIVERSITY HOSPITAL; FORCED EXPIRATORY VOLUME; LUNG; LUNG DIFFUSION CAPACITY; PATHOPHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; SARCOIDOSIS; VITAL CAPACITY;

ADULT; ANXIETY; COGNITIVE DYSFUNCTION; DEPRESSION; DYSPNEA; FATIGUE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DIFFUSING CAPACITY; QUALITY OF LIFE; SARCOIDOSIS; SMALL FIBER NEUROPATHY; SOCIAL SUPPORT; SURVEYS AND QUESTIONNAIRES; VITAL CAPACITY;

EID: 85035120921     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2017.11.008     Document Type: Article

References (69)

1. Statement on sarcoidosis, Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and other Granulomatous disorders (WASOG) adopted by the ATS board of directors and by the ERS executive committee, February 1999. Am. J. Respir. Crit. Care Med. 160:2 (1999), 736–755.
2. Valeyre, D., Prasse, A., Nunes, H., Uzunhan, Y., Brillet, P.Y., Muller-Quernheim, J., Sarcoidosis. Lancet 383:9923 (2014), 1155–1167.
3. Drent, M., Lower, E.E., De Vries, J., Sarcoidosis-associated fatigue. Eur Respir J 40:1 (2012), 255–263.
4. Drent, M., Strookappe, B., Hoitsma, E., De Vries, J., Consequences of sarcoidosis. Clin. Chest Med. 36:4 (2015), 727–737.
5. Marcellis, R.G., Lenssen, A.F., Elfferich, M.D., De Vries, J., Kassim, S., Foerster, K., Drent, M., Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur. Respir. J. 38:3 (2011), 628–634.
6. Fleischer, M., Hinz, A., Brahler, E., Wirtz, H., Bosse-Henck, A., Factors associated with fatigue in sarcoidosis. Respir. Care 59:7 (2014), 1086–1094.
7. Saligan, L.N., The relationship between physical activity, functional performance and fatigue in sarcoidosis. J. Clin. Nurs. 23:15–16 (2014), 2376–2378.
8. Michielsen, H.J., Drent, M., Peros-Golubicic, T., De Vries, J., Fatigue is associated with quality of life in sarcoidosis patients. Chest 130:4 (2006), 989–994.
9. Korenromp, I.H., Heijnen, C.J., Vogels, O.J., van den Bosch, J.M., Grutters, J.C., Characterization of chronic fatigue in patients with sarcoidosis in clinical remission. Chest 140:2 (2011), 441–447.
10. de Kleijn, W.P., Drent, M., Vermunt, J.K., Shigemitsu, H., De Vries, J., Types of fatigue in sarcoidosis patients. J. Psychosom. Res. 71:6 (2011), 416–422.
11. Sharma, O.P., Fatigue and sarcoidosis. Eur. Respir. J. 13:4 (1999), 713–714.
12. Elfferich, M.D., Nelemans, P.J., Ponds, R.W., De Vries, J., Wijnen, P.A., Drent, M., Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration 80:3 (2010), 212–219.
13. Van Manen, M.J., Wapenaar, M., Strookappe, B., Drent, M., Elfferich, M., de Vries, J., Gosker, H.R., Birring, S.S., Patel, A.S., van den Toorn, L., van den Blink, B., Boomars, K., Hoitsma, E., Wijsenbeek, M.S., Validation of the King's sarcoidosis questionnaire (KSQ) in a Dutch sarcoidosis population. Sarcoidosis Vasc. Diffuse Lung Dis. 33:1 (2016), 75–82.
14. Marcellis, R.G., Veeke, M.A.F., Mesters, I., Drent, M., Bie de, R.A., Vries de, G.J., Lenssen, A.F., Does physical training reduce fatigue in sarcoidosis?. Sarcoidosis Vasc. Diffuse Lung Dis. 32:1 (2015), 53–62.
15. Strookappe, B., De Vries, J., Elfferich, M., Kuijpers, P., Knevel, T., Drent, M., Predictors of fatigue in sarcoidosis: the value of exercise testing. Respir. Med. 116 (2016), 49–54.
16. Atkins, C.P., Gilbert, D., Brockwell, C., Robinson, S., Wilson, A.M., Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases. Sarcoidosis Vasc. Diffuse Lung Dis. 33:2 (2016), 130–138.
17. Judson, M.A., Chaudhry, H., Louis, A., Lee, K., Yucel, R., The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis. Respir. Med. 109:4 (2015), 526–531.
18. Korenromp, I.H., Grutters, J.C., van den Bosch, J.M., Heijnen, C.J., Post-inflammatory fatigue in sarcoidosis: personality profiles, psychological symptoms and stress hormones. J. Psychosom. Res. 72:2 (2012), 97–102.
19. Braam, A.W., de Haan, S.N., Vorselaars, A.D., Rijkers, G.T., Grutters, J.C., van den Elshout, F.J., Korenromp, I.H., Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosis. Brain Behav. Immun. 33 (2013), 57–64.
20. Marcellis, R.G., Lenssen, A.F., Kleynen, S., De Vries, J., Drent, M., Exercise capacity, muscle strength, and fatigue in sarcoidosis: a follow-up study. Lung 191:3 (2013), 247–256.
21. Wirnsberger, R.M., De Vries, J., Breteler, M.H., van Heck, G.L., Wouters, E.F., Drent, M., Evaluation of quality of life in sarcoidosis patients. Respir. Med. 92:5 (1998), 750–756.
22. de Kleijn, W.P., De Vries, J., Lower, E.E., Elfferich, M.D., Baughman, R.P., Drent, M., Fatigue in sarcoidosis: a systematic review. Curr. Opin. Pulm. Med. 15:5 (2009), 499–506.
23. De Vries, J., Drent, M., Relationship between perceived stress and sarcoidosis in a Dutch patient population. Sarcoidosis Vasc. Diffuse Lung Dis. 21:1 (2004), 57–63.
24. Verbraecken, J., Hoitsma, E., van der Grinten, C.P., Cobben, N.A., Wouters, E.F., Drent, M., Sleep disturbances associated with periodic leg movements in chronic sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 21:2 (2004), 137–146.
25. Taylor, S.E., Aspinwall, L.G., Mediating and moderating processes in psychosocial stress. Kaplan, H.B., (eds.) Psychosocial Stress: Perspectives on Structures, Theory, Life-course and Methods, 1996, Academic Press, San Diego, CA, 71–110.
26. Van der Ploeg, H.M., Defares, P.B., Spielberger, C.D., ZBV: a Dutch-language Adaptation of the Spielberger State-trait Anxiety Inventory. 1980, Swets & Zeitlinger, Lisse, The Netherlands.
27. Radloff, L.S., The CESD-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977), 385–401.
28. Hoitsma, E., De Vries, J., Drent, M., The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis. Respir. Med. 105:1 (2011), 95–100.
29. Broadbent, D.E., Cooper, P.F., FitzGerald, P., Parkes, K.R., The cognitive failures questionnaire (CFQ) and its correlates. Br. J. Clin. Psychol. 21:Pt 1 (1982), 1–16.
30. Borg, G.A., Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc 14:5 (1982), 377–381.
31. Beekman, A.T., Deeg, D.J., Van Limbeek, J., Braam, A.W., De Vries, M.Z., Van Tilburg, W., Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands. Psychol. Med. 27:1 (1997), 231–235.
32. De Vries, J., The Perceived Social Support Scale. Dutch version, 1998, Tilburg University, Tilburg.
33. Blumenthal, J.A., Burg, M.M., Barefoot, J., Williams, R.B., Haney, T., Zimet, G., Social support, type A behavior, and coronary artery disease. Psychosom. Med. 49:4 (1987), 331–340.
34. De Vries, J., Michielsen, H., Van Heck, G.L., Drent, M., Measuring fatigue in sarcoidosis: the fatigue assessment scale (FAS). Br. J. Health Psychol. 9:Pt 3 (2004), 279–291.
35. Michielsen, H.J., De Vries, J., Van Heck, G.L., Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale. J. Psychosom. Res. 54:4 (2003), 345–352.
36. Hu, L.T., Bentler, P.M., Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct. Equat Model 6 (1999), 1–55.
37. Bentler, P.M., Comparative fit indexes in structural models. Psychol. Bull. 107:2 (1990), 238–246.
38. Kline, R.B., Principles and practice of structural equation modeling. Little, T.D., (eds.) Methodology in the Social Sciences, 2005, Guilford Press, New York, 510.
39. Browne, M.W., Cudeck, R., Alternative ways of assessing model fit. Sociol. Methods Res. 21 (1992), 230–258.
40. Drent, M., Wirnsberger, R.M., de Vries, J., van Dieijen-Visser, M.P., Wouters, E.F., Schols, A.M., Association of fatigue with an acute phase response in sarcoidosis. Eur. Respir. J. 13:4 (1999), 718–722.
41. Bosse-Henck, A., Koch, R., Wirtz, H., Hinz, A., Fatigue and excessive daytime sleepiness in sarcoidosis: prevalence, predictors, and relationships between the two symptoms. Respiration 94:2 (2017), 186–197.
42. Spanjer, J., Groothoff, J.W., Brouwer, S., Instruments used to assess functional limitations in workers applying for disability benefit: a systematic review. Disabil. Rehabil. 33:23–24 (2011), 2143–2150.
43. Cleutjens, F.A., Janssen, D.J., Ponds, R.W., Dijkstra, J.B., Wouters, E.F., COgnitive-pulmonary disease. Biomed. Res. Int., 2014, 2014, 697825.
44. Cox, C.E., Donohue, J.F., Brown, C.D., Kataria, Y.P., Judson, M.A., Health-related quality of life of persons with sarcoidosis. Chest 125:3 (2004), 997–1004.
45. Chang, B., Steimel, J., Moller, D.R., Baughman, R.P., Judson, M.A., Yeager, H. Jr., Teirstein, A.S., Rossman, M.D., Rand, C.S., Depression in sarcoidosis. Am. J. Respir. Crit. Care Med. 163:2 (2001), 329–334.
46. De Vries, J., Rothkrantz-Kos, S., van Dieijen-Visser, M.P., Drent, M., The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 21:2 (2004), 127–136.
47. Drent, M., Wirnsberger, R.M., Breteler, M.H., Kock, L.M., de Vries, J., Wouters, E.F., Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 15:1 (1998), 59–66.
48. Elfferich, M.D., De Vries, J., Drent, M., Type D or 'distressed' personality in sarcoidosis and idiopathic pulmonary fibrosis. Sarcoidosis Vasc. Diffuse Lung Dis. 28:1 (2011), 65–71.
49. Katon, W., Lin, E.H., Kroenke, K., The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen. Hosp. Psychiatry 29:2 (2007), 147–155.
50. Stepanski, E.J., Walker, M.S., Schwartzberg, L.S., Blakely, L.J., Ong, J.C., Houts, A.C., The relation of trouble sleeping, depressed mood, pain, and fatigue in patients with cancer. J. Clin. Sleep. Med. 5:2 (2009), 132–136.
51. Freeman, R., Komaroff, A.L., Does the chronic fatigue syndrome involve the autonomic nervous system?. Am. J. Med. 102:4 (1997), 357–364.
52. Chaturvedi, S.K., Peter Maguire, G., Somashekar, B.S., Somatization in cancer. Int. Rev. Psychiatry 18:1 (2006), 49–54.
53. de Kleijn, W.P., Drent, M., De Vries, J., Nature of fatigue moderates depressive symptoms and anxiety in sarcoidosis. Br. J. Health Psychol. 18:2 (2013), 439–452.
54. Hinz, A., Brähler, E., Möde, R., Wirtz, H., Bosse-Henck, A., Anxiety and depression in sarcoidosis: the influence of age, gender, affected organs, concomitant diseases and dyspnea. Sarcoidosis Vasc. Diffuse Lung Dis. 29 (2012), 139–146.
55. de Boer, S., Kolbe, J., Wilsher, M.L., The relationships among dyspnoea, health-related quality of life and psychological factors in sarcoidosis. Respirology 19:7 (2014), 1019–1024.
56. Korenromp, I.H., Grutters, J.C., van den Bosch, J.M., Zanen, P., Kavelaars, A., Heijnen, C.J., Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue. Brain Behav. Immun. 25:7 (2011), 1498–1502.
57. Kim, Y.K., Na, K.S., Shin, K.H., Jung, H.Y., Choi, S.H., Kim, J.B., Cytokine imbalance in the pathophysiology of major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 31:5 (2007), 1044–1053.
58. Hoitsma, E., Marziniak, M., Faber, C.G., Reulen, J.P., Sommer, C., De Baets, M., Drent, M., Small fibre neuropathy in sarcoidosis. Lancet 359:9323 (2002), 2085–2086.
59. Hoitsma, E., Drent, M., Sharma, O.P., A pragmatic approach to diagnosing and treating neurosarcoidosis in the 21st century. Curr. Opin. Pulm. Med. 16:5 (2010), 472–479.
60. Voortman, M., Fritz, D., Vogels, O.J.M., Eftimov, F., van de Beek, D., Brouwer, M.C., Drent, M., Small fiber neuropathy: a disabling and underrecognized syndrome. Curr. Opin. Pulm. Med. 23:5 (2017), 447–457.
61. Hoitsma, E., Drent, M., Verstraete, E., Faber, C.G., Troost, J., Spaans, F., Reulen, J.P., Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis. Clin. Neurophysiol. 114:12 (2003), 2326–2333.
62. Hinz, A., Fleischer, M., Brahler, E., Wirtz, H., Bosse-Henck, A., Fatigue in patients with sarcoidosis, compared with the general population. Gen. Hosp. Psychiatry 33:5 (2011), 462–468.
63. James, D.G., Complications of sarcoidosis. Chronic fatigue syndr. Sarcoidosis 10:1 (1993), 1–3.
64. Michielsen, H.J., Willemsen, T.M., Croon, M.A., De Vries, J., Van Heck, G.L., Determinants of general fatigue and emotional exhaustion: a prospective study. Psychol. Health 19:2 (2004), 223–235.
65. Gvozdenovic, B.S., Mihailovic-Vucinic, V., Ilic-Dudvarski, A., Zugic, V., Judson, M.A., Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respir. Med. 102:11 (2008), 1636–1642.
66. Goracci, A., Fagiolini, A., Martinucci, M., Calossi, S., Rossi, S., Santomauro, T., Mazzi, A., Penza, F., Fossi, A., Bargagli, E., Pieroni, M.G., Rottoli, P., Castrogiovanni, P., Quality of life, anxiety and depression in sarcoidosis. Gen. Hosp. Psychiatry 30:5 (2008), 441–445.
67. Klonoff, E.A., Kleinhenz, M.E., Psychological factors in sarcoidosis: the relationship between life stress and pulmonary function. Sarcoidosis 10:2 (1993), 118–124.
68. Clark, M.R., Katon, W., Russo, J., Kith, P., Sintay, M., Buchwald, D., Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study. Am. J. Med. 98:2 (1995), 187–195.
69. Brooks, S.K., Chalder, T., Rimes, K.A., Chronic fatigue syndrome: cognitive, behavioural and emotional processing vulnerability factors. Behav. Cogn. Psychother. 45:2 (2017), 156–169.